Clinical Trial Update: Combination CAR-T Cell Therapy Targeting Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for a combination CAR-T cell therapy targeting hematological malignancies, currently recruiting for B-cell malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies

Drugs mentioned

• CAR-T cell therapy (combination)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: B-cell Malignancies | Phase 1, Phase 2 | Status: RECRUITING